|
|
|
|
|
|
Ibio Inc (IBIO)
|
|
0.40 +0.01 (+2.91%)
|
6/22/2017 3:59pm
|
|
Open:
|
0.38
|
Pre. Close:
|
0.39
|
|
High:
|
0.40
|
Low:
|
0.37
|
|
Volume:
|
51,901
|
Market Cap:
|
35.65M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.4 - 0.43
|
0.43 - 0.47
|
|
Low:
|
0.34 - 0.35
|
0.35 - 0.36
|
|
Close:
|
0.38 - 0.41
|
0.41 - 0.45
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-22 4:38:55 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 0.53  One year: 0.61
|
|
Support:
|
Support1: 0.39 Support2: 0.35
|
|
Resistance:
|
Resistance1:
0.45 Resistance2: 0.53
|
|
Pivot:
|
0.38
|
|
Moving Averages:
|
MA(5): 0.38 MA(20): 0.38
MA(100): 0.41 MA(250): 0.48 
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9):
|
|
%K %D:
|
%K(14,3): 42.90 %D(3): 35.27
|
|
RSI:
|
RSI(14): 55.88
|
|
52-Week:
|
High: 0.80
Low: 0.33 Change(%): -37.5
|
|
Average Vol(K):
|
3-Month: 70
10-Days 40
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.IBIO has closed below upper band by 22.1%. Bollinger Bands are 14% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Thu, 04 May 2017 20:03:45 GMT
iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting
Thu, 26 Jul 2012 11:03:24 GMT
iBio, Inc. and GE Healthcare form new global alliance
Tue, 05 Jul 2016 12:22:30 GMT
iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate
Thu, 14 Jan 2016 14:03:45 GMT
iBio, Inc. (IBIO), Eastern Capital Enter JV to Develop Plant-Made Pharmaceuticals
Sun, 17 May 2015 13:41:15 GMT
What Happened to Ibio Inc (NYSEMKT:IBIO)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
